|
1
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Goding Sauer A, Jemal A and Siegel RL:
Breast cancer statistics, 2019. CA Cancer J Clin. 69:438–451. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279-e2892014. View Article : Google Scholar
|
|
3
|
Waks AG and Winer EP: Breast cancer
treatment: A review. JAMA. 321:288–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun L, He M, Xu N, Xu DH, Ben-David Y,
Yang ZY and Li YJ: Regulation of RAB22A by mir-193b inhibits breast
cancer growth and metastasis mediated by exosomes. Int J Oncol.
53:2705–2714. 2018.PubMed/NCBI
|
|
5
|
Zhang L and Yu S: Role of miR-520b in
non-small cell lung cancer. Exp Ther Med. 16:3987–3995.
2018.PubMed/NCBI
|
|
6
|
Xiong F, Liu K, Zhang F, Sha K, Wang X,
Guo X and Huang N: miR-204 inhibits the proliferation and invasion
of renal cell carcinoma by inhibiting RAB22A expression. Oncol Rep.
35:3000–3008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang D, Liu G and Wang K: miR-203 acts as
a tumor suppressor gene in osteosarcoma by regulating RAB22A. PLoS
One. 10:e01322252015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He H, Dai F, Yu L, She X, Zhao Y, Jiang J,
Chen X and Zhao S: Identification and characterization of nine
novel human small GTPases showing variable expressions in liver
cancer tissues. Gene Expr. 10:231–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okamoto I, Pirker C, Bilban M, Berger W,
Losert D, Marosi C, Haas OA, Wolff K and Pehamberger H: Seven novel
and stable translocations associated with oncogenic gene expression
in malignant melanoma. Neoplasia. 7:303–311. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Y, Wu B, Li JH, Nan G, Jiang JL and
Chen ZN: Rab22a enhances CD147 recycling and is required for lung
cancer cell migration and invasion. Exp Cell Res. 357:9–16. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stenmark H: Rab GTPases as coordinators of
vesicle traffic. Nat Rev Mol Cell Biol. 10:513–525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kauppi M, Simonsen A, Bremnes B, Vieira A,
Callaghan J, Stenmark H and Olkkonen VM: The small GTPase Rab22
interacts with EEA1 and controls endosomal membrane trafficking. J
Cell Sci. 115:899–911. 2002.PubMed/NCBI
|
|
13
|
Magadan JG, Barbieri MA, Mesa R, Stahl PD
and Mayorga LS: Rab22a regulates the sorting of transferrin to
recycling endosomes. Mol Cell Biol. 26:2595–2614. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weigert R, Yeung AC, Li J and Donaldson
JG: Rab22a regulates the recycling of membrane proteins
internalized independently of clathrin. Mol Biol Cell.
15:3758–3770. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang T, Gilkes DM, Takano N, Xiang L, Luo
W, Bishop CJ, Chaturvedi P, Green JJ and Semenza GL:
Hypoxia-inducible factors and RAB22A mediate formation of
microvesicles that stimulate breast cancer invasion and metastasis.
Proc Natl Acad Sci USA. 111:E3234–E3242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang F, Zhu J, Wu J, Lv T, Xiang H, Tian
J, Zhang Y and Huang Z: O(2)-3-Aminopropyl diazeniumdiolates
suppress the progression of highly metastatic triple-negative
breast cancer by inhibition of microvesicle formation via nitric
oxide-based epigenetic regulation. Chem Sci. 9:6893–6898. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su F, Chen Y, Zhu S, Li F, Zhao S, Wu L,
Chen X and Su J: RAB22A overexpression promotes the tumor growth of
melanoma. Oncotarget. 7:71744–71753. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Bennett CN, Tomlinson CC, Michalowski AM,
Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J,
Piwinica-Worms H, Caplen NJ, et al: Cross-species genomic and
functional analyses identify a combination therapy using a CHK1
inhibitor and a ribonucleotide reductase inhibitor to treat
triple-negative breast cancer. Breast Cancer Res. 14:R1092012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tan MH, De S, Bebek G, Orloff MS,
Wesolowski R, Downs-Kelly E, Budd GT, Stark GR and Eng C: Specific
kinesin expression profiles associated with taxane resistance in
basal-like breast cancer. Breast Cancer Res Treat. 131:849–858.
2012. View Article : Google Scholar
|
|
21
|
Haakensen VD, Biong M, Lingjaerde OC,
Holmen MM, Frantzen JO, Chen Y, Navjord D, Romundstad L, Lüders T,
Bukholm IK, et al: Expression levels of uridine
5′-diphospho-gluc-uronosyltransferase genes in breast tissue from
healthy women are associated with mammographic density. Breast
Cancer Res. 12:R652010. View Article : Google Scholar
|
|
22
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiao Y, Fu Z, Li Y, Meng L and Liu Y: High
EIF2B5 mRNA expression and its prognostic significance in liver
cancer: A study based on the TCGA and GEO database. Cancer Manag
Res. 10:6003–6014. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cebrian I, Croce C, Guerrero NA, Blanchard
N and Mayorga LS: Rab22a controls MHC-I intracellular trafficking
and antigen cross-presentation by dendritic cells. EMBO Rep.
17:1753–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shakya S, Sharma P, Bhatt AM, Jani RA,
Delevoye C and Setty SR: Rab22A recruits BLOC-1 and BLOC-2 to
promote the biogenesis of recycling endosomes. EMBO Rep.
19:e459182018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ishibashi K, Kanno E, Itoh T and Fukuda M:
Identification and characterization of a novel Tre-2/Bub2/Cdc16
(TBC) protein that possesses Rab3A-GAP activity. Genes Cells.
14:41–52. 2009. View Article : Google Scholar
|
|
28
|
Mesa R, Magadan J, Barbieri A, Lopez C,
Stahl PD and Mayorga LS: Overexpression of Rab22a hampers the
transport between endosomes and the Golgi apparatus. Exp Cell Res.
304:339–353. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pfeffer SR: Rab GTPases: Master regulators
that establish the secretory and endocytic pathways. Mol Biol Cell.
28:712–715. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maldonado-Baez L and Donaldson JG: Hook1,
microtubules, and Rab22: Mediators of selective sorting of
clathrin-independent endocytic cargo proteins on endosomes.
Bioarchitecture. 3:141–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goldenring JR: A central role for vesicle
trafficking in epithelial neoplasia: Intracellular highways to
carcinogenesis. Nat Rev Cancer. 13:813–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mosesson Y, Mills GB and Yarden Y:
Derailed endocytosis: An emerging feature of cancer. Nat Rev
Cancer. 8:835–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qi S, Su L, Li J, Zhao P, Zhang Q, Niu X,
Liu J, Jia G, Wei X, Tavernier J, et al: YIPF2 is a novel Rab-GDF
that enhances HCC malignant phenotypes by facilitating CD147
endocytic recycle. Cell Death Dis. 10:4622019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng S, Jiang F, Ge D, Tang J, Chen H,
Yang J, Yao Y, Yan J, Qiu J, Yin Z, et al: LncRNA
SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of
osteosarcoma. Biomed Pharmacother. 112:1086952019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mayorga LS and Cebrian I: Rab22a: A novel
regulator of immune functions. Mol Immunol. 11:87–92. 2018.
|
|
36
|
Rodriguez-Furlan C, Domozych D, Qian W,
Enquist PA, Li X, Zhang C, Schenk R, Winbigler HS, Jackson W,
Raikhel NV and Hicks GR: Interaction between VPS35 and RABG3f is
necessary as a checkpoint to control fusion of late compartments
with the vacuole. Proc Natl Acad Sci USA. 116:21291–21301. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rajarajacholan UK, Thalappilly S and
Riabowol K: The ING1a tumor suppressor regulates endocytosis to
induce cellular senescence via the Rb-E2F pathway. PLoS Biol.
11:e10015022013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo ML, Gong C, Chen CH, Hu H, Huang P,
Zheng M, Yao Y, Wei S, Wulf G, Lieberman J, et al: The Rab2A GTPase
promotes breast cancer stem cells and tumorigenesis via Erk
signaling activation. Cell Rep. 11:111–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang HL, Sun HF, Gao SP, Li LD, Hu X, Wu
J and Jin W: Loss of RAB1B promotes triple-negative breast cancer
metastasis by activating TGF-β/SMAD signaling. Oncotarget.
6:16352–16365. 2015.PubMed/NCBI
|
|
40
|
Wu H, Carvalho P and Voeltz GK: Here,
there, and everywhere: The importance of ER membrane contact sites.
Science. 361:64012018. View Article : Google Scholar
|
